The presence of clonally expanded populations of T cells and B cells in the inflamed tissue of patients with type 1 diabetes (diabetes) and in multiple sclerosis (MS) has long suggested that self-antigens are driving the disease process. This PPG had brought together investigators applying highly sensitive, novel techniques including the use of self-antigen tetramers and single cell cloning methods to interrogate the antibodies and T cells in the pancreatic lymph nodes of patients with diabetes and brain tissue of patients with MS. We have made significant progress in providing new evidence for the role of two candidate antigens, insulin and MOG, in these disease processes. These findings, along with the recent surprising results that infusions of anti-CD20 mAb therapy targeting B cells may have efficacy in human autoimmune diseases has led us to the underlying hypothesis of this PPG effort that alterations in the function of autoantigen-specific B cells, acting as antigen presenting cells, are central in the induction of human autoimmune diseases.
In Aim 1, we will complete our initial efforts to identify the autoantigens driving clonal expansion of B cells in MS plaques and now examine diabetes islet tissue and lymph nodes. We will determine BCR sequences of individual B cells isolated by laser microdissection, followed by affinity purification of antigens with reconstructed antibodies and molecular definition of targets by tandem mass spectrometry.
In Aim 2, we will interrogate the autoreactive B cells by a novel, nanowell-based technology and determine whether the B cells of patients with autoimmune diseases are pro-inflammatory. This interrogation of defined antigen specific cells will focus on functional cytokine secretion and phenotypic cell surface markers.
In Aim 3, we will examine whether B cells and autoantibodies present at the sites of inflammation directly contribute to disease pathology through autoantigen presentation. In collaboration with the Kuchroo lab, we will study the ability of human recombinant antibodies generated in Aim 1 to induce demyelination in EAE models as well as the ability of B cells that express human BCRs to induce differentiation of autoreactive T cells into pathogenic effectors. High-affinity insulin-specific autoantibodies recognize the same insulin A1-15 chain epitope as human T cells, and we will examine whether these BCRs protect the T cell epitope from premature degradation during antigen presentation, a question that is clinically relevant because the affinity of insulin autoantibodies correlates with progression to diabetes. The clear association of autoantibodies with predicting susceptibility to autoimmune diabetes and the presence of anti- MOG autoantibodies in MS plaque tissue together suggest the importance of investigating B cells in these human autoimmune diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI045757-14
Application #
8379873
Study Section
Special Emphasis Panel (ZAI1-SR-I)
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
14
Fiscal Year
2012
Total Cost
$605,389
Indirect Cost
$110,752
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Urso, Katia; Alvarez, David; Cremasco, Viviana et al. (2016) IL4RA on lymphatic endothelial cells promotes T cell egress during sclerodermatous graft versus host disease. JCI Insight 1:
Adams, Jarrett J; Narayanan, Samanthi; Birnbaum, Michael E et al. (2016) Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity. Nat Immunol 17:87-94
Longbrake, Erin E; Hafler, David A (2016) Linking Genotype to Clinical Phenotype in Multiple Sclerosis: In Search of the Holy Grail. JAMA Neurol 73:777-8
Singer, Meromit; Wang, Chao; Cong, Le et al. (2016) A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells. Cell 166:1500-1511.e9
Fernandez-Carbonell, Cristina; Vargas-Lowy, David; Musallam, Alexander et al. (2016) Clinical and MRI phenotype of children with MOG antibodies. Mult Scler 22:174-84
Cao, Yonghao; Nylander, Alyssa; Ramanan, Sriram et al. (2016) CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment. Neurology 86:1553-6
Axisa, Pierre-Paul; Hafler, David A (2016) Multiple sclerosis: genetics, biomarkers, treatments. Curr Opin Neurol 29:345-53
Lowther, Daniel E; Goods, Brittany A; Lucca, Liliana E et al. (2016) PD-1 marks dysfunctional regulatory T cells in malignant gliomas. JCI Insight 1:
Chastre, Anne; Hafler, David A; O'Connor, Kevin C (2016) Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis. N Engl J Med 374:1495-6
Astarita, Jillian L; Cremasco, Viviana; Fu, Jianxin et al. (2015) The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture. Nat Immunol 16:75-84

Showing the most recent 10 out of 117 publications